Erich Horsley

About

Erich Horsley is the Chief Executive Officer of Biosplice Therapeutics, a clinical-stage biotech company developing small-molecule therapeutics for osteoarthritis, cancer, Alzheimer's disease, and other degenerative conditions. Biosplice's official bio says he previously was a Partner and founding member of Intervale Capital and earlier worked at Watermill Group and Morgan Stanley. His background spans private equity, investment banking, and biotech company leadership.

Areas of interest